Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NY: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration
CANbridge Returns NERLYNX® Rights in Greater China to Puma Biotechnology as the Two Parties Terminate License Agreement and Settle Arbitration 
From Business Wire News Releases
Puma Biotechnology and Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China
Puma Biotechnology and Pierre Fabre added Greater China to their license agreement. Puma and CANbridge Pharma terminated their Greater China agreement 
From Business Wire News Releases
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
Puma Biotechnology released its financial results for the fourth quarter and year ended Dec. 31, 2020 on Feb. 25, 2020. 
From Business Wire News Releases
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags APLS CNCE APYX
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags NLSP SGMO RVNC
From Benzinga
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2020 Financial Results
Puma Biotechnology will host a conference call at 1:30 p.m. PST on February 25 following release of its 4Q-2020 financial results. 
From Business Wire News Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology reported inducement awards for the month of January 2021 as required by Nasdaq Listing Rule 5635(c)(4). 
From Business Wire News Releases
Puma Biotechnology Presents Interim Results from the Phase II SUMMIT Trial of Neratinib for EGFR Exon 18-Mutated, Metastatic Non-Small Cell Lung Cancer at WCLC 2020
Puma Biotechnology presented interim results from the Phase II SUMMIT Trial of Neratinib for EGFR exon 18-mutated, metastatic NSCLC at WCLC 2020. 
From Business Wire News Releases
Puma Biotechnology to Present at the B. Riley Oncology Investor Conference
Alan Auerbach, CEO and President of Puma Biotechnology, will present a company update at the B. Riley Oncology Investor Conference on Jan. 21. 
From Business Wire News Releases
Puma Biotechnology Presents Interim Results from the Biliary Tract Cancers Cohort of the Phase II SUMMIT “Basket” Trial of Neratinib at ASCO GI
Puma Biotechnology presented interim results from its biliary tract cancers cohort of the Phase II SUMMIT “basket” trial at ASCO GI 2021, 
From Business Wire News Releases
ONK Therapeutics Appoints Hugh O’Dowd as Independent Chairman
ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has appointed Hugh O’Dowd as Director and independent Non-executive Chairman of its Board of... 
From Business Wire News Releases
Puma Biotechnology to Present at the J.P. Morgan Healthcare Conference
Alan Auerbach will present an overview of Puma Biotechnology at the J.P. Morgan Healthcare Conference on Jan. 14 at 10:50 a.m. EST. 
From Business Wire News Releases
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Market News MRKR NGM
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 18.53% to $2.11 during Monday's after-market session. This security ... 
Tags SBBP AEMD Market News
From Benzinga
Puma Biotechnology to Present at the H.C. Wainwright VIRTUAL BioConnect Conference
Alan Auerbach will present a Puma Biotechnology update at H.C. Wainwright's BioConnect VIRTUAL Conference beginning on Jan. 11, 2021 at 6:00 am EST. 
From Business Wire News Releases
First Week of PBYI February 2021 Options Trading
Investors in Puma Biotechnology Inc (PBYI) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PBYI... 
Tags Stocks
From Market News Video
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology reported inducement awards for November 2020 as required by Nasdaq Listing Rule 5635(c)(4) . 
From Business Wire News Releases
Puma Biotechnology Presents Efficacy and Safety Outcomes from the Phase III NALA Trial at the 2020 SABCS
Puma Biotechnology presented efficacy and safety outcomes from the Phase III NALA Trial in a Spotlight Poster at the 2020 Virtual SABCS. 
From Business Wire News Releases
The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BIIB BCRX SLS
From Benzinga
Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at the 2020 SABCS
Puma Biotechnology presented final overall survival analysis from its Phase III ExteNET Trial at the 2020 San Antonio Breast Cancer Symposium. 
From Business Wire News Releases
Puma Biotechnology Presents Updated Results from the Phase II SUMMIT Trial of Neratinib for HER2-Mutant, HR-Positive Metastatic Breast Cancer at SABCS 2020
Puma Biotechnology presented updated results from its Phase II SUMMIT trial in a Spotlight Poster at the 2020 San Antonio Breast Cancer Symposium. 
From Business Wire News Releases
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags INCY NVCN RCUS
From Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ... 
Tags MGNX Earnings APTO
From Benzinga
Puma Biotechnology, Inc. Prevails Before European Patent Office Board of Appeals in Decision Upholding European Patent (EP 1848414) as Granted
European Patent Office Upholds Puma Biotechnology's Patent Position on EP 1848414 as Granted. 
From Business Wire News Releases
Noteworthy Monday Option Activity: SKT, BTAI, PBYI
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Tanger Factory Outlet Centers, Inc. (SKT), where a total of 63,675 contracts have traded so... 
Tags Stocks
From Market News Video
Puma Biotechnology to Present Neratinib Data at the San Antonio Breast Cancer Symposium (SABCS)
Puma Biotechnology will present 10 posters at the 2020 Virtual San Antonio Breast Cancer Symposium, which will be held Dec. 8-11, 2020. 
From Business Wire News Releases
Notable Wednesday Option Activity: RKT, PBYI, APD
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Rocket Companies Inc Class A (RKT), where a total of 171,541 contracts have traded so far,... 
Tags Stocks
From Market News Video
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology reported its inducement awards for Oct. 2020 as required by Nasdaq Listing Rule 5635(c)(4). 
From Business Wire News Releases
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GLYC SNDX BLFS
From Benzinga
Puma Biotechnology Announces Interim Results from the Phase II SUMMIT Trial of Neratinib for EGFR Exon 18 Mutated, Metastatic Non-Small Cell Lung Cancer
On Nov. 5, 2020, Puma Biotechnology released interim results from its Phase II SUMMIT Trial of Neratinib for EGFR Exon 18 mutated, metastatic NSCLC. 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.